ABSTRACT
Domestic andforeign professional diagnostic communities recommend to develop new or confirm literature reference ranges for each laboratory parameter. Bearing in mind the importance of antithrombin-III levels for anticoagulation therapy, we determined their reference ranges for the adult population of the Astrakhan region and compared them with those obtained by other authors and presented in the instructions for use of commercial kits for measuring ant ithrombin-III. Our reference ranges differ from those cited in the said instructions.
Subject(s)
Antithrombin III/metabolism , Blood Coagulation Disorders/blood , Blood Coagulation Factors/metabolism , Blood Coagulation Tests/instrumentation , Adult , Blood Coagulation Disorders/diagnosis , Equipment Design , Female , Humans , Male , Middle Aged , Reference ValuesABSTRACT
The antagonistic activity of 4 strains of bifidobacteria (B. adolescentis 2 F1, B. longum Z4, B. breve R2 and B. bifidum G1), isolated from the vagina of healthy females of the reproductive age, with respect to Escherichia coli, Klebsiella ozaenae, Staphylococcus aureus, Enterococcus faecalis, Pseudomonas aeruginosa and Gardnerella vaginalis were studied in vitro and in vivo. The in vitro experiments revealed that all above-mentioned bifidobacteria were capable of inhibiting the growth of all indicator bacterial strains. Still of all the bifidobacteria under study had different levels of activity. B. adolescentis strain 2 F1 exhibited the highest inhibiting activity in vitro. In contrast to in vitro experiments, in vivo experiments with B. breve R2 demonstrated its high antagonistic activity with respect to E. coli. The data thus obtained indicate that in the study of antagonistic activity the use of the in vivo model as also expedient, for it is mainly in vivo that probiotic preparations show their activity.
